0001823359-23-000002.txt : 20230317 0001823359-23-000002.hdr.sgml : 20230317 20230317155538 ACCESSION NUMBER: 0001823359-23-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230317 DATE AS OF CHANGE: 20230317 EFFECTIVENESS DATE: 20230317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eumentis Therapeutics, Inc. CENTRAL INDEX KEY: 0001823359 IRS NUMBER: 842626747 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-476232 FILM NUMBER: 23742363 BUSINESS ADDRESS: STREET 1: 508 DUDLEY ROAD STREET 2: SUITE 105 CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 6174133020 MAIL ADDRESS: STREET 1: 508 DUDLEY ROAD STREET 2: SUITE 105 CITY: NEWTON STATE: MA ZIP: 02459 D 1 primary_doc.xml X0708 D LIVE 0001823359 Eumentis Therapeutics, Inc. 508 DUDLEY ROAD SUITE 105 NEWTON MA MASSACHUSETTS 02459 6174133020 DELAWARE None None Corporation true 2019 mark Tepper 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Executive Officer Director James Larrick 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Director Andrew Pearlman 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Director Randall Marshall 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Executive Officer Maryann Bryla 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Director Kim Patrick 508 Dudley Road Suite 105 Newton MA MASSACHUSETTS 02459 Director Pharmaceuticals Decline to Disclose 06b false true true true false 100000 20000000 4000000 16000000 $20,000,000 debt financing with tranches over three (3) years with initial drawn-down of $4,000,000. false 1 0 0 0 false Eumentis Therapeutics, Inc. Mark Tepper Mark Tepper President 2023-03-17